tradingkey.logo

Boundless Bio Announces Portfolio Prioritization And Runway Extension

ReutersMay 23, 2025 8:54 PM

Boundless Bio Inc BOLD.O:

  • BOUNDLESS BIO ANNOUNCES PORTFOLIO PRIORITIZATION AND RUNWAY EXTENSION

  • BOUNDLESS BIO INC - PRIORITIZES BBI-355/BBI-825 COMBINATION AND BBI-940

  • BOUNDLESS BIO INC - DISCONTINUES CURRENT ARMS OF BBI-355 IN POTENTIATE TRIAL

  • BOUNDLESS BIO INC - TO EVALUATE BBI-355/BBI-825 COMBINATION IN 2025

  • BOUNDLESS BIO INC - REDUCES WORKFORCE BY ONE-THIRD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI